138 related articles for article (PubMed ID: 12220192)
1. Affinity of Stat2 for the subunits of the interferon alpha receptor.
Saleh AZ; Nguyen VP; Krolewski JJ
Biochemistry; 2002 Sep; 41(37):11261-8. PubMed ID: 12220192
[TBL] [Abstract][Full Text] [Related]
2. Stat2 binding to the interferon-alpha receptor 2 subunit is not required for interferon-alpha signaling.
Nguyen VP; Saleh AZ; Arch AE; Yan H; Piazza F; Kim J; Krolewski JJ
J Biol Chem; 2002 Mar; 277(12):9713-21. PubMed ID: 11786546
[TBL] [Abstract][Full Text] [Related]
3. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.
Li X; Leung S; Kerr IM; Stark GR
Mol Cell Biol; 1997 Apr; 17(4):2048-56. PubMed ID: 9121453
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
[TBL] [Abstract][Full Text] [Related]
5. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3.
Nadeau OW; Domanski P; Usacheva A; Uddin S; Platanias LC; Pitha P; Raz R; Levy D; Majchrzak B; Fish E; Colamonici OR
J Biol Chem; 1999 Feb; 274(7):4045-52. PubMed ID: 9933596
[TBL] [Abstract][Full Text] [Related]
6. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acid residues critical for the Src-homology 2 domain-dependent docking of Stat2 to the interferon alpha receptor.
Krishnan K; Singh B; Krolewski JJ
J Biol Chem; 1998 Jul; 273(31):19495-501. PubMed ID: 9677371
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
9. Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2.
El Fiky A; Arch AE; Krolewski JJ
J Cell Physiol; 2005 Aug; 204(2):567-73. PubMed ID: 15717316
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activities of the soluble extracellular domains of type I interferon receptors.
Han CS; Chen Y; Ezashi T; Roberts RM
Proc Natl Acad Sci U S A; 2001 May; 98(11):6138-43. PubMed ID: 11344274
[TBL] [Abstract][Full Text] [Related]
12. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.
Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C
EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877
[TBL] [Abstract][Full Text] [Related]
13. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
15. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site.
Roisman LC; Jaitin DA; Baker DP; Schreiber G
J Mol Biol; 2005 Oct; 353(2):271-81. PubMed ID: 16171819
[TBL] [Abstract][Full Text] [Related]
17. STAT2 nuclear trafficking.
Banninger G; Reich NC
J Biol Chem; 2004 Sep; 279(38):39199-206. PubMed ID: 15175343
[TBL] [Abstract][Full Text] [Related]
18. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action.
Pfeffer LM; Basu L; Pfeffer SR; Yang CH; Murti A; Russell-Harde D; Croze E
J Biol Chem; 1997 Apr; 272(17):11002-5. PubMed ID: 9110990
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.
Deshpande A; Putcha BD; Kuruganti S; Walter MR
Protein Sci; 2013 Aug; 22(8):1100-8. PubMed ID: 23703950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
